| UniProt ID | IKZF2_HUMAN | |
|---|---|---|
| UniProt AC | Q9UKS7 | |
| Protein Name | Zinc finger protein Helios | |
| Gene Name | IKZF2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 526 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Associates with Ikaros at centromeric heterochromatin.. | |
| Protein Sequence | METEAIDGYITCDNELSPEREHSNMAIDLTSSTPNGQHASPSHMTSTNSVKLEMQSDEECDRKPLSREDEIRGHDEGSSLEEPLIESSEVADNRKVQELQGEGGIRLPNGKLKCDVCGMVCIGPNVLMVHKRSHTGERPFHCNQCGASFTQKGNLLRHIKLHSGEKPFKCPFCSYACRRRDALTGHLRTHSVGKPHKCNYCGRSYKQRSSLEEHKERCHNYLQNVSMEAAGQVMSHHVPPMEDCKEQEPIMDNNISLVPFERPAVIEKLTGNMGKRKSSTPQKFVGEKLMRFSYPDIHFDMNLTYEKEAELMQSHMMDQAINNAITYLGAEALHPLMQHPPSTIAEVAPVISSAYSQVYHPNRIERPISRETADSHENNMDGPISLIRPKSRPQEREASPSNSCLDSTDSESSHDDHQSYQGHPALNPKRKQSPAYMKEDVKALDTTKAPKGSLKDIYKVFNGEGEQIRAFKCEHCRVLFLDHVMYTIHMGCHGYRDPLECNICGYRSQDRYEFSSHIVRGEHTFH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----METEAIDGYI -----CCCCEECEEE | 29.44 | 26074081 | |
| 9 | Phosphorylation | ETEAIDGYITCDNEL CCCEECEEEECCCCC | 6.84 | 26074081 | |
| 11 | Phosphorylation | EAIDGYITCDNELSP CEECEEEECCCCCCC | 12.81 | 26074081 | |
| 17 | Phosphorylation | ITCDNELSPEREHSN EECCCCCCCCCCCCC | 20.66 | 30108239 | |
| 23 | Phosphorylation | LSPEREHSNMAIDLT CCCCCCCCCCEEECC | 24.45 | 26074081 | |
| 30 | Phosphorylation | SNMAIDLTSSTPNGQ CCCEEECCCCCCCCC | 19.51 | 26074081 | |
| 31 | Phosphorylation | NMAIDLTSSTPNGQH CCEEECCCCCCCCCC | 39.24 | 26074081 | |
| 32 | Phosphorylation | MAIDLTSSTPNGQHA CEEECCCCCCCCCCC | 42.52 | 26074081 | |
| 33 | Phosphorylation | AIDLTSSTPNGQHAS EEECCCCCCCCCCCC | 22.12 | 30108239 | |
| 40 | Phosphorylation | TPNGQHASPSHMTST CCCCCCCCCCCCCCC | 25.47 | 30108239 | |
| 42 | Phosphorylation | NGQHASPSHMTSTNS CCCCCCCCCCCCCCC | 24.32 | 30108239 | |
| 45 | Phosphorylation | HASPSHMTSTNSVKL CCCCCCCCCCCCCEE | 27.29 | 26074081 | |
| 46 | Phosphorylation | ASPSHMTSTNSVKLE CCCCCCCCCCCCEEE | 20.30 | 26074081 | |
| 47 | Phosphorylation | SPSHMTSTNSVKLEM CCCCCCCCCCCEEEE | 23.50 | 26074081 | |
| 49 | Phosphorylation | SHMTSTNSVKLEMQS CCCCCCCCCEEEECC | 22.25 | 26074081 | |
| 56 | Phosphorylation | SVKLEMQSDEECDRK CCEEEECCCCCCCCC | 45.75 | 23401153 | |
| 63 | Acetylation | SDEECDRKPLSREDE CCCCCCCCCCCHHHH | 36.74 | 25953088 | |
| 63 | Ubiquitination | SDEECDRKPLSREDE CCCCCCCCCCCHHHH | 36.74 | - | |
| 66 | Phosphorylation | ECDRKPLSREDEIRG CCCCCCCCHHHHHCC | 42.00 | 26657352 | |
| 78 | Phosphorylation | IRGHDEGSSLEEPLI HCCCCCCCCCCCCCC | 29.69 | 23401153 | |
| 79 | Phosphorylation | RGHDEGSSLEEPLIE CCCCCCCCCCCCCCC | 51.13 | 30266825 | |
| 87 | Phosphorylation | LEEPLIESSEVADNR CCCCCCCCCHHHCCH | 25.46 | 27251275 | |
| 88 | Phosphorylation | EEPLIESSEVADNRK CCCCCCCCHHHCCHH | 24.25 | 30576142 | |
| 95 | Ubiquitination | SEVADNRKVQELQGE CHHHCCHHHHHHCCC | 55.30 | - | |
| 95 | Sumoylation | SEVADNRKVQELQGE CHHHCCHHHHHHCCC | 55.30 | 28112733 | |
| 111 | Acetylation | GIRLPNGKLKCDVCG CEECCCCCEEECCCE | 51.95 | 25953088 | |
| 135 | Phosphorylation | MVHKRSHTGERPFHC EEECCCCCCCCCCCC | 41.82 | - | |
| 148 | Phosphorylation | HCNQCGASFTQKGNL CCCCCCCCEECCCCC | 17.70 | 17924679 | |
| 160 | Ubiquitination | GNLLRHIKLHSGEKP CCCCEEEEECCCCCC | 33.74 | - | |
| 163 | Phosphorylation | LRHIKLHSGEKPFKC CEEEEECCCCCCCCC | 60.11 | 23401153 | |
| 166 | Sumoylation | IKLHSGEKPFKCPFC EEECCCCCCCCCCCC | 60.32 | - | |
| 166 | Ubiquitination | IKLHSGEKPFKCPFC EEECCCCCCCCCCCC | 60.32 | - | |
| 166 | Acetylation | IKLHSGEKPFKCPFC EEECCCCCCCCCCCC | 60.32 | 72618283 | |
| 166 | Sumoylation | IKLHSGEKPFKCPFC EEECCCCCCCCCCCC | 60.32 | - | |
| 174 | Phosphorylation | PFKCPFCSYACRRRD CCCCCCCHHHHHCHH | 19.02 | 17924679 | |
| 175 | Phosphorylation | FKCPFCSYACRRRDA CCCCCCHHHHHCHHH | 15.76 | 17924679 | |
| 200 | Phosphorylation | GKPHKCNYCGRSYKQ CCCCCCCCCCCCHHH | 13.02 | - | |
| 200 (in isoform 4) | Phosphorylation | - | 13.02 | - | |
| 209 | Phosphorylation | GRSYKQRSSLEEHKE CCCHHHCCCHHHHHH | 36.46 | - | |
| 210 | Phosphorylation | RSYKQRSSLEEHKER CCHHHCCCHHHHHHH | 41.82 | - | |
| 215 | Ubiquitination | RSSLEEHKERCHNYL CCCHHHHHHHHHHHH | 50.57 | - | |
| 226 | Phosphorylation | HNYLQNVSMEAAGQV HHHHHHCCHHHHHHH | 20.60 | 26074081 | |
| 235 | Phosphorylation | EAAGQVMSHHVPPME HHHHHHHHCCCCCHH | 16.16 | 30576142 | |
| 256 | Phosphorylation | PIMDNNISLVPFERP CCCCCCEEEEECCCH | 25.99 | 30576142 | |
| 262 | Ubiquitination | ISLVPFERPAVIEKL EEEEECCCHHHHHHH | 25.51 | 19608861 | |
| 262 | Acetylation | ISLVPFERPAVIEKL EEEEECCCHHHHHHH | 25.51 | 19608861 | |
| 268 | Ubiquitination | ERPAVIEKLTGNMGK CCHHHHHHHHCCCCC | 39.98 | - | |
| 270 | Phosphorylation | PAVIEKLTGNMGKRK HHHHHHHHCCCCCCC | 37.26 | 26074081 | |
| 275 | Ubiquitination | KLTGNMGKRKSSTPQ HHHCCCCCCCCCCCC | 45.98 | - | |
| 275 | Acetylation | KLTGNMGKRKSSTPQ HHHCCCCCCCCCCCC | 45.98 | 25953088 | |
| 278 | Phosphorylation | GNMGKRKSSTPQKFV CCCCCCCCCCCCHHH | 43.40 | 26074081 | |
| 279 | Phosphorylation | NMGKRKSSTPQKFVG CCCCCCCCCCCHHHH | 47.33 | 26074081 | |
| 280 | Phosphorylation | MGKRKSSTPQKFVGE CCCCCCCCCCHHHHH | 36.51 | 26074081 | |
| 283 | Ubiquitination | RKSSTPQKFVGEKLM CCCCCCCHHHHHHHH | 43.13 | - | |
| 283 | Acetylation | RKSSTPQKFVGEKLM CCCCCCCHHHHHHHH | 43.13 | 25953088 | |
| 288 | Ubiquitination | PQKFVGEKLMRFSYP CCHHHHHHHHHCCCC | 41.47 | 19608861 | |
| 288 | Acetylation | PQKFVGEKLMRFSYP CCHHHHHHHHHCCCC | 41.47 | 19608861 | |
| 293 | Phosphorylation | GEKLMRFSYPDIHFD HHHHHHCCCCCEEEE | 25.95 | - | |
| 342 | O-linked_Glycosylation | PLMQHPPSTIAEVAP HHHHCCCCHHHHHHH | 36.58 | 29351928 | |
| 352 | Phosphorylation | AEVAPVISSAYSQVY HHHHHHHHHHHHHCC | 14.78 | 26074081 | |
| 353 | Phosphorylation | EVAPVISSAYSQVYH HHHHHHHHHHHHCCC | 21.80 | 26074081 | |
| 355 | Phosphorylation | APVISSAYSQVYHPN HHHHHHHHHHCCCCC | 11.11 | 26074081 | |
| 356 | Phosphorylation | PVISSAYSQVYHPNR HHHHHHHHHCCCCCC | 16.94 | 26074081 | |
| 359 | Phosphorylation | SSAYSQVYHPNRIER HHHHHHCCCCCCCCC | 12.15 | 26074081 | |
| 369 | Phosphorylation | NRIERPISRETADSH CCCCCCCCHHHCCCC | 27.09 | 30266825 | |
| 372 | Phosphorylation | ERPISRETADSHENN CCCCCHHHCCCCCCC | 34.35 | 23401153 | |
| 375 | Phosphorylation | ISRETADSHENNMDG CCHHHCCCCCCCCCC | 30.18 | 22115753 | |
| 385 | Phosphorylation | NNMDGPISLIRPKSR CCCCCCCEEECCCCC | 22.37 | 26074081 | |
| 390 | Ubiquitination | PISLIRPKSRPQERE CCEEECCCCCCCCCC | 49.61 | - | |
| 391 | Phosphorylation | ISLIRPKSRPQEREA CEEECCCCCCCCCCC | 52.45 | 26074081 | |
| 399 | Phosphorylation | RPQEREASPSNSCLD CCCCCCCCCCCCCCC | 24.90 | 26074081 | |
| 401 | Phosphorylation | QEREASPSNSCLDST CCCCCCCCCCCCCCC | 38.59 | 26074081 | |
| 403 | Phosphorylation | REASPSNSCLDSTDS CCCCCCCCCCCCCCC | 22.01 | 26074081 | |
| 408 | Phosphorylation | SNSCLDSTDSESSHD CCCCCCCCCCCCCCC | 43.12 | 30576142 | |
| 419 | Phosphorylation | SSHDDHQSYQGHPAL CCCCCHHHHCCCCCC | 18.92 | 26074081 | |
| 420 | Phosphorylation | SHDDHQSYQGHPALN CCCCHHHHCCCCCCC | 16.37 | 26074081 | |
| 433 | Phosphorylation | LNPKRKQSPAYMKED CCCCCCCCCCHHHHH | 17.96 | 23401153 | |
| 436 | Phosphorylation | KRKQSPAYMKEDVKA CCCCCCCHHHHHHHH | 16.47 | 29978859 | |
| 438 | Ubiquitination | KQSPAYMKEDVKALD CCCCCHHHHHHHHHC | 37.78 | - | |
| 442 | Sumoylation | AYMKEDVKALDTTKA CHHHHHHHHHCCCCC | 56.40 | - | |
| 442 | Ubiquitination | AYMKEDVKALDTTKA CHHHHHHHHHCCCCC | 56.40 | - | |
| 442 | Sumoylation | AYMKEDVKALDTTKA CHHHHHHHHHCCCCC | 56.40 | 28112733 | |
| 446 | Phosphorylation | EDVKALDTTKAPKGS HHHHHHCCCCCCCCC | 30.92 | 28122231 | |
| 447 | Phosphorylation | DVKALDTTKAPKGSL HHHHHCCCCCCCCCH | 25.52 | 17081983 | |
| 448 | Ubiquitination | VKALDTTKAPKGSLK HHHHCCCCCCCCCHH | 65.86 | - | |
| 448 | Sumoylation | VKALDTTKAPKGSLK HHHHCCCCCCCCCHH | 65.86 | 28112733 | |
| 451 | Ubiquitination | LDTTKAPKGSLKDIY HCCCCCCCCCHHHHH | 67.02 | - | |
| 453 | Phosphorylation | TTKAPKGSLKDIYKV CCCCCCCCHHHHHHH | 38.07 | 30108239 | |
| 455 | Ubiquitination | KAPKGSLKDIYKVFN CCCCCCHHHHHHHHC | 43.72 | - | |
| 459 | Ubiquitination | GSLKDIYKVFNGEGE CCHHHHHHHHCCCCC | 40.46 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IKZF2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IKZF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IKZF2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HDAC4_HUMAN | HDAC4 | physical | 12943985 | |
| SIN3A_HUMAN | SIN3A | physical | 12015313 | |
| SIN3B_HUMAN | SIN3B | physical | 12015313 | |
| CHD4_HUMAN | CHD4 | physical | 12015313 | |
| HDAC2_HUMAN | HDAC2 | physical | 12015313 | |
| HDAC5_HUMAN | HDAC5 | physical | 12015313 | |
| IKZF1_HUMAN | IKZF1 | physical | 9560339 | |
| IKZF3_HUMAN | IKZF3 | physical | 9560339 | |
| IKZF2_HUMAN | IKZF2 | physical | 9560339 | |
| LONF1_HUMAN | LONRF1 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-288, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56; SER-78 AND SER-79,AND MASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174 AND TYR-175, ANDMASS SPECTROMETRY. | |